Ubrolexin Suspension zur intramammären Anwendung bei laktierenden Milchkühen

Recall | Veterinary Medicines | 25/03/2022

The marketing authorisation holder informed its customers on March 21, 2022, that a leakage at the base of the injector was detected in a small percentage of injectors in the course of production. This can lead to an unforeseen leakage of the suspension. For this reason, the affected batch is recalled.

Name of the medicinal product Ubrolexin Suspension zur intramammären Anwendung bei laktierenden Milchkühen
Marketing authorisation number(s) 8-00759
CIP code 3525826
Marketing authorisation holder Boehringer Ingelheim Vetmedica GmbH
Batch number(s) K866
Expiry date 11/30/2024
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3812
Email

Further inquiry note